Global CNS focus ProPhase specializes in applied measurement in CNS areas including psychiatry, neurology and rare/orphan diseases, offering scalable measurement science services that could align with sponsors running multinational CNS trials seeking standardized assessment across regions.

Clinical trial breadth With experience supporting trials across 60+ countries and 18 primary indications, ProPhase can position itself as a versatile partner for sponsors needing protocol consultation, scale development, rater training, and in-study QA across diverse therapeutic areas.

End-to-end services ProPhase provides a comprehensive service suite from measurement selection and scale licensing to linguistic validation, data collection via multiple media, and statistical reporting, enabling a single vendor to manage measurement integrity throughout a trial.

Pediatric and orphan expertise Specialized capabilities in pediatric populations and orphan/rare diseases offer a path to win business from sponsors with challenging trial populations and regulatory- or market-access-driven measurement needs that require validated, regionally adaptable tools.

Growth opportunities Low current revenue suggests an expansion runway; targeted outreach to mid-to-large CROs and pharma sponsors with CNS, oncology, dermatology and rare-disease programs could yield sizeable opportunities leveraging ProPhase’s measurement science and quality assurance strengths.